Literature DB >> 11684135

Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores.

R W Wilkinson1, A E Lee-MacAry, D Davies, D Snary, E L Ross.   

Abstract

Using flow cytometry (FCM), an assay has been developed for the determination of antibody-dependent cell-mediated cytotoxicity (ADCC). Target cells were labelled with a membrane dye, PKH-26, to allow discrimination when incubated with effector cells and antibody. Post-incubation, cell death within the PKH-26+ target cell population was assessed by the addition of the viability probe TO-PRO-3 iodide (TP3). This ADCC method allows analysis to be conducted on a single cell basis and overcomes the need for radiochemicals. This communication indicates that the assay is accurate and reproducible with the potential to be a useful tool for evaluating the therapeutic potential of antibodies and antibody-based reagents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684135     DOI: 10.1016/s0022-1759(01)00474-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.

Authors:  Bhavin S Parekh; Elaine Berger; Sharon Sibley; Suntara Cahya; Liqun Xiao; Melinda Ann LaCerte; Peter Vaillancourt; Scott Wooden; Dennis Gately
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

2.  Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.

Authors:  Marcus Järås; Petra Johnels; Nils Hansen; Helena Agerstam; Panagiotis Tsapogas; Marianne Rissler; Carin Lassen; Tor Olofsson; Ole Weis Bjerrum; Johan Richter; Thoas Fioretos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  A high-performance, non-radioactive potency assay for measuring cytotoxicity: A full substitute of the chromium-release assay targeting the regulatory-compliance objective.

Authors:  Alexis Rossignol; Véronique Bonnaudet; Béatrice Clémenceau; Henri Vié; Laurent Bretaudeau
Journal:  MAbs       Date:  2017-02-08       Impact factor: 5.857

4.  Tracking immune cell proliferation and cytotoxic potential using flow cytometry.

Authors:  Joseph D Tario; Katharine A Muirhead; Dalin Pan; Mark E Munson; Paul K Wallace
Journal:  Methods Mol Biol       Date:  2011

5.  Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.

Authors:  Michael Brusilovsky; Olga Radinsky; Limor Cohen; Rami Yossef; Avishai Shemesh; Alex Braiman; Ofer Mandelboim; Kerry S Campbell; Angel Porgador
Journal:  Eur J Immunol       Date:  2015-01-21       Impact factor: 5.532

Review 6.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

7.  Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy.

Authors:  Kristopher A Sarosiek; Hovav Nechushtan; Xiaoqing Lu; Joseph D Rosenblatt; Izidore S Lossos
Journal:  Br J Haematol       Date:  2009-08-19       Impact factor: 6.998

8.  Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition.

Authors:  Anna Lünemann; Jan D Lünemann; Susanne Roberts; Brady Messmer; Rosa Barreira da Silva; Cedric S Raine; Christian Münz
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.

Authors:  Nidia Alvarez-Rueda; Ariane Desselle; Denis Cochonneau; Tanguy Chaumette; Béatrice Clemenceau; Stéphanie Leprieur; Gwenola Bougras; Stéphane Supiot; Jean-Marie Mussini; Jacques Barbet; Julie Saba; François Paris; Jacques Aubry; Stéphane Birklé
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

10.  Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia.

Authors:  Mickaël Terme; Mylène Dorvillius; Denis Cochonneau; Tanguy Chaumette; Wenhua Xiao; Mitchell B Diccianni; Jacques Barbet; Alice L Yu; François Paris; Linda S Sorkin; Stéphane Birklé
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.